Blessie Elizabeth Nelson MBBS, DMRT (@blessienelson) 's Twitter Profile
Blessie Elizabeth Nelson MBBS, DMRT

@blessienelson

Assistant Professor, General & Breast Medical Oncology | MD Anderson | Focused on Early Phase Trials, Multimodal Precision Oncology & Health Disparities

ID: 1516506999122546698

calendar_today19-04-2022 20:00:28

433 Tweet

218 Followers

183 Following

Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile Photo

Precision gene- and immune-targeted therapies show impressive results in metastatic solid cancers. Time to move to newly diagnosed disease as we did in CML— once a fatal leukemia, now near normal life expectancy 🎯💡🎯 doi.org/10.1016/j.medj…

Precision gene- and immune-targeted therapies show impressive results in metastatic solid cancers. 
Time to move to newly diagnosed disease as we did in CML— once a fatal leukemia, now near normal life expectancy 🎯💡🎯
doi.org/10.1016/j.medj…
Winn Awards (@winnawards) 's Twitter Profile Photo

Happy weekend! ✈️ Tomorrow we're headed to the #HealthEquityCongress in Atlanta, where Megan Becker, the ED of our Winn CDA program, will be presenting this poster. Stop by and say hi! #BetterScienceForAll

Happy weekend! ✈️ Tomorrow we're headed to the #HealthEquityCongress in Atlanta, where Megan Becker, the ED of our Winn CDA program, will be presenting this poster. Stop by and say hi! #BetterScienceForAll
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Skin related side effects (rashes in particular) are not only observed with EFGR inhibitors, but also with recently developed KRAS inhibitors. Nice work being done at MD Anderson Cancer Center by the team of David S. Hong MD & Anisha B. Patel MD to ameliorate this AE for patient tolerability.

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Pancreatic cancer is often diagnosed at later stages, making treatment more difficult. In the latest Cancerwise podcast episode, our experts discuss the latest research and emerging treatments from the lab and clinic. Listen here: bit.ly/3ERncxZ Anirban Maitra

Pancreatic cancer is often diagnosed at later stages, making treatment more difficult.

In the latest Cancerwise podcast episode, our experts discuss the latest research and emerging treatments from the lab and clinic. Listen here: bit.ly/3ERncxZ <a href="/Aiims1742/">Anirban Maitra</a>
Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile Photo

Look whom I found at SWOG—Drs Herbst and Pusztai— brilliant colleagues from our MD Anderson days. They are both at Yale now. Time flies

Look whom I found at SWOG—Drs Herbst and Pusztai— brilliant colleagues from our MD Anderson days.   They are both at Yale now.  Time flies
Helen M. Johnson, MD, IBCLC (@helenmjohnsonmd) 's Twitter Profile Photo

Final debate of #ASBrS2025: pN+ after neoadjuvant therapy - Dr Marie Jeanne Vrancken Peeters argued for completion #ALND while Dr Walter Weber argued for #radiation. Concluded with an expert summary by Dr Kelly Hunt Kelly K Hunt MD Anderson Cancer Center Craig Carson ASBrS Henry Kuerer

Final debate of #ASBrS2025: pN+ after neoadjuvant therapy - Dr Marie Jeanne Vrancken Peeters argued for completion #ALND while Dr Walter Weber argued for #radiation. Concluded with an expert summary by Dr Kelly Hunt <a href="/KellyKhunt/">Kelly K Hunt</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/crgcrsn/">Craig Carson</a> <a href="/ASBrS/">ASBrS</a> <a href="/HenryKuerer/">Henry Kuerer</a>
Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: CD56 expression modulates NAD+ metabolic landscape and may help predict sensitivity to anti-CD38 therapies & Isa-based regimens may provide comparable or even greater benefits than Dara-based regimens: pubmed.ncbi.nlm.nih.gov/40316562/. #mmsm

#Myeloma Paper of the Day: CD56 expression modulates NAD+ metabolic landscape and may help predict sensitivity to anti-CD38 therapies &amp; Isa-based regimens may provide comparable or even greater benefits than Dara-based regimens: pubmed.ncbi.nlm.nih.gov/40316562/. #mmsm
Fumiko Ladd Chino, MD, FASCO (@fumikochino) 's Twitter Profile Photo

Deeply saddened that the entire team NCI Cancer Control National Cancer Institute PDQ Cancer Information has been eliminated. Our evidence-based summaries were updated throughout the year with the latest evidence and supported informed decision making between clinicians & patients across the US. 🇺🇸

Deeply saddened that the entire team <a href="/NCICancerCtrl/">NCI Cancer Control</a> <a href="/theNCI/">National Cancer Institute</a> PDQ Cancer Information has been eliminated. 

Our evidence-based summaries were updated throughout the year with the latest evidence and supported informed decision making between clinicians &amp; patients across the US. 🇺🇸
Sapna Patel (@drsapnapatel) 's Twitter Profile Photo

Thanks to everyone who helped make my (almost) 1st year back in Colorado CU Cancer Center extraordinary! ✨ Especially true for our #melanoma team! ✨ news.cuanschutz.edu/cancer-center/… via @gotosage

VJ Oncology (@vjoncology) 's Twitter Profile Photo

🎥Blessie Elizabeth Nelson MBBS, DMRT from MD Anderson Cancer Center shares AACR Project GENIE data on metaplastic #breastcancer: high frequency of targetable mutations (TP53, PIK3CA), copy number changes, and mutual exclusivity patterns support precision therapy: ➡️ow.ly/zkq950VU06v⬅️ AACR #BCSM

Elizabeth McKenna (@elizsmckenna) 's Twitter Profile Photo

Highly successful first day getting acclimated in Italy making my way to the GRC Cancer Genetics & Epigenetics Meeting! 🇻🇦🇮🇹

Highly successful first day getting acclimated in Italy making my way to the GRC Cancer Genetics &amp; Epigenetics Meeting! 🇻🇦🇮🇹